Updated: May 27
TBnet Spring Scientific Meeting today – Thursday, May 27 @15:00 -18:00
At the TBnet Spring Scientific Meeting where we will provide information about ongoing and future TBnet studies. Program and link to the meeting here: https://www.tbnet.eu/post/spring-scientific-tbnet-meeting-may-27-2021
Recently, TBnet has announced a call for projects. Several new proposals have been submitted and will be presented during the TBnet Scientific Meeting. We would like to encourage TBnet members to join and find out more about the projects and how to participate in these studies. We also hope for more projects to be submitted in future to TBnet network to drive clinical TB research in European Region.
For inspiration, we invited a speaker who’s clinical trial resulted in an important finding. We are very happy that Payam Nahid, Professor of Medicine at the University of California, San Francisco, will present on "Four-month rifapentine regimens with or without moxifloxacin for tuberculosis” during the TBnt Scientific meeting.
“Dr. Nahid is Associate Director of Clinical Trials Operations in the UCSF Office of Research, and Medical Director of the UCSF CTSA Trials Innovation Network Hub. His research includes the conduct of clinical trials and translational research in TB with the goal of improving the care of patients with TB and HIV/TB worldwide. Dr. Nahid leads NIH and CDC-funded field studies of new TB diagnostics, Phase 2 and 3 clinical trials in TB therapeutics and latent TB infection treatment implementation studies.” Read more about our guest speaker here: https://profiles.ucsf.edu/payam.nahid
European Advance Course on Clinical Tuberculosis EACCTB 2021
The EACCTB is a clinically oriented course for clinicians, scientists, public health officers and nurses.
This year´s DZIF-TB course at the Research Center Borstel is organized together with the Karolinska Institute, TBnet, FILHA and KNCV. The course will take place online June 09 and 10 2021. IT's a hybrid event and you can participate online.
The agenda and further information can be found here:
TBnet & ptbnet – conference contributions
In May 2021 there have been two conferences where TBnet and ptbnet members actively engaged.
On the 25 of May a group of TBnet steering committee members took part in All-Russian Infection Congress by developing a symposium “Tuberculosis & COVID-19: Russian & European experiences”.
Dr Anna Starshinova was the main organizer. Dr. Kontsevaya, Dr. Guglielmetti, Dr. Kuksa, Dr. Dominguez and Dr. Brinkmann presented several talks on covid-19 effect on TB services, TB clinical trials, BCG vaccination & covid-19 as well as pediatric TB & covid-19. Russian colleagues, Dr. Karev, Dr. Gubkina, Dr. Kudryavtsev, Dr. Belyaeva Dr. Chuzhov and Dr. Nazarenko presented talks on differential diagnostics and treatment of TB and covid-19 in Russia and response of Russian TB service to covid-19.
For the ongoing ESPID 2021 - https://espidmeeting.org/, ptbnet has prepared a range of talks:
Wed 26.05.2021 10:00-11:30: Live oral presentations on TB and HIV with presentations on TB new diagnostics (Laura Olbrich), transcriptomic signatures (Ortensia Vito), BCG and immune response (Laure Pittet) and radiological challenges for TB diagnosis (Alicia Hernanz Lobo)
Thu 27.05.2021 12:00-13:00: Meet the expert on TB led by Marc Tebruegge and Folke Brinkmann
Fri 28.05.2021 10:00-11:30: ESPID/FIND Joint symposium on modern approaches to diagnose lung infections With keynote talks on digital tools to diagnose pneumonia in children (Rigveda Kadam) and ultrasound to diagnose lung infections (Noemi Boillat Blanco).
We are delighted to let you know that Dr. Danilo Buonsenso, ptbnet has been awarded the ESPID Best Presentation Award for his abstract summarizing the ptbnet QFT-Plus study!
Many greetings to Danylo and all ptbnet colleagues!